newsfilter
← Latest News
GlobeNewswire·

Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD

BOSTON and LONDON, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Orchard Therapeutics (NASDAQ:ORTX), a global gene therapy leader, today announced the Swiss Agency for Therapeutic Products (Swissmedic) has approved Libmeldy®